These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12413584)

  • 1. Differences between neonates and adults in plasmin inhibitory and antifibrinolytic action of aprotinin.
    Zenker M; Ries M
    Thromb Res; 2002 Jul; 107(1-2):17-21. PubMed ID: 12413584
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery.
    Phillips LL; Weiss R; Wolf C
    Ann N Y Acad Sci; 1968 Jun; 146(2):737-44. PubMed ID: 4239442
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
    Al-Horani RA; Desai UR
    Med Res Rev; 2014 Nov; 34(6):1168-216. PubMed ID: 24659483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass].
    Risch A; Dorscheid E; Stein G; Seyfert UT; Grundmann U
    Anaesthesist; 2000 Apr; 49(4):279-85. PubMed ID: 10840537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents.
    Flight S; Johnson L; Trabi M; Gaffney P; Lavin M; de Jersey J; Masci P
    Pathophysiol Haemost Thromb; 2005; 34(4-5):188-93. PubMed ID: 16707925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization.
    Minami K; Notohamiprodjo G; Buschler H; Prohaska W; Reichelt W; Körfer R
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):934-6. PubMed ID: 7694000
    [No Abstract]   [Full Text] [Related]  

  • 11. Basis of antifibrinolytic therapy.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():35-40. PubMed ID: 6159375
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation.
    Sperzel M; Huetter J
    J Thromb Haemost; 2007 Oct; 5(10):2113-8. PubMed ID: 17666018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Considerations on fibrinolysis with particular reference to a biological inhibitor of plasmin].
    Coelho MC; Tim AR
    Hospital (Rio J); 1968 Jul; 74(1):307-14. PubMed ID: 4238955
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative studies of fibrinolytic inhibitors in vitro.
    Maki M; Beller FK
    Thromb Diath Haemorrh; 1966 Dec; 16(3):668-86. PubMed ID: 4231539
    [No Abstract]   [Full Text] [Related]  

  • 15. Aprotinin: antifibrinolytic and anti-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass.
    Donahue MA; Price PM
    Dynamics; 2002; 13(3):16-23. PubMed ID: 12640841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of antiplasmin on fibrinolysis and fibrinogenolysis].
    Bratus' GM; Byshevskiĭ ASh
    Ukr Biokhim Zh; 1971; 43(2):178-82. PubMed ID: 4254692
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC; Tsai IH
    Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin and the TEG.
    Jenkins IR
    Anaesth Intensive Care; 1997 Apr; 25(2):195-6. PubMed ID: 9127666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.